Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 2
1984 1
1986 2
1987 2
1988 2
1989 1
1990 2
1992 2
1993 3
1994 2
1995 1
1996 1
1997 1
1998 4
2000 1
2001 1
2002 1
2003 2
2005 1
2006 1
2007 4
2009 1
2012 1
2013 2
2014 1
2017 3
2018 2
2019 2
2020 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Gastrinomas: Medical or Surgical Treatment.
Norton JA, Foster DS, Ito T, Jensen RT. Norton JA, et al. Endocrinol Metab Clin North Am. 2018 Sep;47(3):577-601. doi: 10.1016/j.ecl.2018.04.009. Endocrinol Metab Clin North Am. 2018. PMID: 30098717 Free PMC article. Review.
This article reviews the role of surgical and medical management in patients with Zollinger-Ellison syndrome (ZES) due to a gastrin-secreting neuroendocrine tumor (gastrinoma). It concentrates on the status at present but also briefly reviews the chang …
This article reviews the role of surgical and medical management in patients with Zollinger-Ellison syndrome (ZES) due to a gastrin-s …
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.
Rossi RE, Elvevi A, Citterio D, Coppa J, Invernizzi P, Mazzaferro V, Massironi S. Rossi RE, et al. World J Gastroenterol. 2021 Sep 21;27(35):5890-5907. doi: 10.3748/wjg.v27.i35.5890. World J Gastroenterol. 2021. PMID: 34629807 Free PMC article. Review.
Zollinger-Ellison syndrome (ZES) associated with pancreatic or duodenal gastrinoma is characterized by gastric acid hypersecretion, which typically leads to gastroesophageal reflux disease, recurrent peptic ulcers, and chronic diarrhea. ...For the localized stage, t …
Zollinger-Ellison syndrome (ZES) associated with pancreatic or duodenal gastrinoma is characterized by gastric acid hypersecre …
An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping.
Kawasaki K, Toshimitsu K, Matano M, Fujita M, Fujii M, Togasaki K, Ebisudani T, Shimokawa M, Takano A, Takahashi S, Ohta Y, Nanki K, Igarashi R, Ishimaru K, Ishida H, Sukawa Y, Sugimoto S, Saito Y, Maejima K, Sasagawa S, Lee H, Kim HG, Ha K, Hamamoto J, Fukunaga K, Maekawa A, Tanabe M, Ishihara S, Hamamoto Y, Yasuda H, Sekine S, Kudo A, Kitagawa Y, Kanai T, Nakagawa H, Sato T. Kawasaki K, et al. Cell. 2020 Nov 25;183(5):1420-1435.e21. doi: 10.1016/j.cell.2020.10.023. Epub 2020 Nov 6. Cell. 2020. PMID: 33159857 Free article.
Gastroenteropancreatic (GEP) neuroendocrine neoplasm (NEN) that consists of neuroendocrine tumor and neuroendocrine carcinoma (NEC) is a lethal but under-investigated disease owing to its rarity. ...
Gastroenteropancreatic (GEP) neuroendocrine neoplasm (NEN) that consists of neuroendocrine tumor and neuroendocrine …
Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.
Lee L, Ramos-Alvarez I, Ito T, Jensen RT. Lee L, et al. Int J Mol Sci. 2019 Oct 16;20(20):5128. doi: 10.3390/ijms20205128. Int J Mol Sci. 2019. PMID: 31623145 Free PMC article. Review.
Zollinger-Ellison syndrome (ZES) is caused by ectopic secretion of gastrin from a neuroendocrine tumor resulting in severe acid hypersecretion requiring life-long antisecretory treatment with PPIs, which are the drugs of choice. ...
Zollinger-Ellison syndrome (ZES) is caused by ectopic secretion of gastrin from a neuroendocrine tumor resulting in sev …
Management of Functional Pancreatic Neuroendocrine Neoplasms.
Magi L, Marasco M, Rinzivillo M, Faggiano A, Panzuto F. Magi L, et al. Curr Treat Options Oncol. 2023 Jul;24(7):725-741. doi: 10.1007/s11864-023-01085-0. Epub 2023 Apr 27. Curr Treat Options Oncol. 2023. PMID: 37103745 Free PMC article. Review.
Functional pancreatic neuroendocrine neoplasms (pNENs) are rare and heterogeneous diseases in terms of both clinical and pathological aspects. ...However, when the disease is not resectable, a broad spectrum of therapeutic options, including locoregional therapy …
Functional pancreatic neuroendocrine neoplasms (pNENs) are rare and heterogeneous diseases in terms of both clinical and pathological …
Diagnosis and management of Zollinger-Ellison syndrome in 2018.
De Angelis C, Cortegoso Valdivia P, Venezia L, Bruno M, Pellicano R. De Angelis C, et al. Minerva Endocrinol. 2018 Jun;43(2):212-220. doi: 10.23736/S0391-1977.17.02745-6. Epub 2017 Sep 25. Minerva Endocrinol. 2018. PMID: 28949124 Review.
Zollinger-Ellison syndrome (ZES) is a clinical syndrome characterized by gastric acid hypersecretion due to the ectopic secretion of gastrin by a gastrinoma, a neuroendocrine tumor (NET) which mostly develops in the duodenum and in the pancreas. …
Zollinger-Ellison syndrome (ZES) is a clinical syndrome characterized by gastric acid hypersecretion due to the ectopic secretion of …
Diagnosis and differential diagnosis of hypergastrinemia.
Arnold R. Arnold R. Wien Klin Wochenschr. 2007;119(19-20):564-9. doi: 10.1007/s00508-007-0878-0. Wien Klin Wochenschr. 2007. PMID: 17985088 Review.
The most frequent conditions of hypergastrinemia in man are the Zollinger-Ellison syndrome with autonomous gastrin hypersecretion by the tumour cell and reactive hypergastrinemia in type A autoimmune chronic atrophic gastritis with achlorhydria causing unrestrained gast …
The most frequent conditions of hypergastrinemia in man are the Zollinger-Ellison syndrome with autonomous gastrin hypersecretion by …
Diagnosis and treatment of gastric neuroendocrine tumours.
Plöckinger U. Plöckinger U. Wien Klin Wochenschr. 2007;119(19-20):570-2. doi: 10.1007/s00508-007-0879-z. Wien Klin Wochenschr. 2007. PMID: 17985089 Review.
Gastric neuroendocrine tumours (NET) are rare. Clinically they are classified in tumours type 1 to 3. ...However, in most patients with MEN-1 the prognosis is due to other manifestations of the disease as duodenal or pancreatic neuroendocrine tumours. Gast …
Gastric neuroendocrine tumours (NET) are rare. Clinically they are classified in tumours type 1 to 3. ...However, in most pati …
Review article: the investigation and management of gastric neuroendocrine tumours.
Basuroy R, Srirajaskanthan R, Prachalias A, Quaglia A, Ramage JK. Basuroy R, et al. Aliment Pharmacol Ther. 2014 May;39(10):1071-84. doi: 10.1111/apt.12698. Epub 2014 Mar 13. Aliment Pharmacol Ther. 2014. PMID: 24628514 Free article. Review.
BACKGROUND: Gastric carcinoids (GCs) or neuroendocrine tumours (NETs) are increasingly identified at endoscopy, and account for 0.6-2% of all gastric polyps identified. ...METHODS: A literature search was conducted through MEDLINE using search terms: gastr …
BACKGROUND: Gastric carcinoids (GCs) or neuroendocrine tumours (NETs) are increasingly identified at endoscopy, and account fo …
Medical treatment of gastrinomas.
Auernhammer CJ, Göke B. Auernhammer CJ, et al. Wien Klin Wochenschr. 2007;119(19-20):609-15. doi: 10.1007/s00508-007-0877-1. Wien Klin Wochenschr. 2007. PMID: 17985097 Review.
Further medical therapy is only recommended in cases of progressive metastatic gastrinoma. ...Prospective future therapeutic strategies may include treatment with novel somatostatin analogues as well as angiogenesis inhibitors and kinase inhibitors targeting …
Further medical therapy is only recommended in cases of progressive metastatic gastrinoma. ...Prospective future therapeuti …
55 results